Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course AmBisome for PKDL
NCT03311607Phase 4Completed
- Sponsor
- Médecins Sans Frontières
- Start
- Apr 2014
- Primary completion
- Oct 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of amphotericin b in Post kala-azar dermal leishmaniasis (PKDL), sponsored by Médecins Sans Frontières. Started Apr 2014; status: completed.
02
Drugs
amphotericin b
03
Conditions
Post kala-azar dermal leishmaniasis (PKDL)
Beyond the preview
Go deeper on NCT03311607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03311607.